Community - Public Portfolios & Trending Stocks | AllInvestView

Earnings Recaps

Browse reported earnings of the most popular stocks

Nov 13, 2026 Nov 12, 2026 Nov 11, 2026 Nov 10, 2026 Nov 9, 2026 Nov 8, 2026 Nov 7, 2026 Nov 6, 2026 Nov 5, 2026 Nov 4, 2026 Nov 3, 2026 Nov 2, 2026 Nov 1, 2026 Oct 31, 2026 Oct 30, 2026 Oct 29, 2026 Oct 28, 2026 Oct 27, 2026 Oct 26, 2026 Oct 25, 2026 Oct 24, 2026 Oct 23, 2026 Oct 22, 2026 Oct 21, 2026 Oct 20, 2026 Oct 19, 2026 Oct 18, 2026 Oct 17, 2026 Oct 16, 2026 Oct 15, 2026 Oct 14, 2026 Oct 13, 2026 Oct 11, 2026 Oct 10, 2026 Oct 9, 2026 Oct 8, 2026 Oct 7, 2026 Oct 3, 2026 Oct 2, 2026 Oct 1, 2026 Sep 30, 2026 Sep 29, 2026 Sep 27, 2026 Sep 26, 2026 Sep 25, 2026 Sep 24, 2026 Sep 23, 2026 Sep 19, 2026 Sep 18, 2026 Sep 17, 2026 Sep 16, 2026 Sep 14, 2026 Sep 13, 2026 Sep 12, 2026 Sep 11, 2026 Sep 10, 2026 Sep 9, 2026 Sep 8, 2026 Sep 5, 2026 Sep 4, 2026 Sep 3, 2026 Sep 2, 2026 Sep 1, 2026 Aug 31, 2026 Aug 30, 2026 Aug 29, 2026 Aug 28, 2026 Aug 27, 2026 Aug 26, 2026 Aug 25, 2026 Aug 23, 2026 Aug 22, 2026 Aug 21, 2026 Aug 20, 2026 Aug 19, 2026 Aug 18, 2026 Aug 17, 2026 Aug 16, 2026 Aug 15, 2026 Aug 14, 2026 Aug 13, 2026 Aug 12, 2026 Aug 11, 2026 Aug 10, 2026 Aug 9, 2026 Aug 8, 2026 Aug 7, 2026 Aug 6, 2026 Aug 5, 2026 Aug 4, 2026 Aug 3, 2026 Aug 2, 2026 Aug 1, 2026 Jul 31, 2026 Jul 30, 2026 Jul 29, 2026 Jul 28, 2026 Jul 27, 2026 Jul 26, 2026 Jul 25, 2026 Jul 24, 2026 Jul 23, 2026 Jul 22, 2026 Jul 21, 2026 Jul 20, 2026 Jul 19, 2026 Jul 18, 2026 Jul 17, 2026 Jul 16, 2026 Jul 12, 2026 Jul 11, 2026 Jul 10, 2026 Jul 9, 2026 Jul 3, 2026 Jul 2, 2026 Jul 1, 2026 Jun 30, 2026 Jun 28, 2026 Jun 27, 2026 Jun 26, 2026 Jun 25, 2026 Jun 24, 2026 Jun 20, 2026 Jun 19, 2026 Jun 18, 2026 Jun 17, 2026 Jun 15, 2026 Jun 14, 2026 Jun 13, 2026 Jun 12, 2026 Jun 11, 2026 Jun 10, 2026 Jun 9, 2026 Jun 6, 2026 Jun 5, 2026 Jun 4, 2026 Jun 3, 2026 Jun 2, 2026 Jun 1, 2026 May 31, 2026 May 30, 2026 May 29, 2026 May 28, 2026 May 27, 2026 May 26, 2026 May 24, 2026 May 23, 2026 May 22, 2026 May 21, 2026 May 20, 2026 May 19, 2026 May 18, 2026 May 17, 2026 May 16, 2026 May 15, 2026 May 14, 2026 May 13, 2026 May 12, 2026 May 11, 2026 May 10, 2026 May 9, 2026 May 8, 2026 May 7, 2026 May 6, 2026 May 5, 2026 May 4, 2026 May 3, 2026 May 2, 2026 May 1, 2026 Apr 30, 2026 Apr 29, 2026 Apr 23, 2026 Apr 22, 2026 Apr 21, 2026 Apr 20, 2026 Apr 18, 2026 Apr 17, 2026 Apr 16, 2026 Apr 15, 2026 Apr 14, 2026 Apr 13, 2026 Apr 10, 2026 Apr 9, 2026 Apr 8, 2026 Apr 7, 2026 Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026

49 companies Today

AbCellera Biologics Inc.

ABCL Q3 2026

Reported: 2026-11-13

AbCellera reported Q3 results centered on positive Phase 2 data for ABCL635, with a 4-week placebo-adjusted reduction of 5.3 moderate-to-severe hot flashes per day. The stock was roughly flat after earnings, down 0.3%, indicating a neutral market reaction.

Key takeaways

ABCL635 reduced daily moderate-to-severe hot flashes by 8.8 from baseline at week 4, versus 3.5 for placebo; the placebo-adjusted reduction was 5.3 events, or 50% of baseline.
Hot-flash severity fell by 1.4 points with ABCL635 and 0.3 points with placebo, a 1.1-point placebo-adjusted difference.
At week 4, 37% of ABCL635 participants had complete resolution of moderate-to-severe events, versus 2.2% on placebo; 78% had a reduction of more than 75%.
Management said the study showed no clear gastrointestinal or liver toxicity signal. Adverse events were numerically more frequent with ABCL635, including headache and fatigue; reported fatigue events were mild.
The company said it is committed to advancing ABCL635 into late-stage development next year.

Astronics Corporation

ATRO Q3 2026

Reported: 2026-11-13

Astronics shares fell 2.7% after earnings, a roughly flat reaction. The quarter showed higher sales and margins, but the improvement included tariff refunds and legal recoveries, while the transcript does not provide enough of the outlook discussion to assess expectations for the remainder of the year.

Key takeaways

Q3 sales reached a record $271.7 million, up 28.5% year over year; adjusted operating income was 18.8% of sales and adjusted EBITDA was 21.8%.
Gross profit rose 46% to $94 million, with gross margin expanding 410 basis points to 34.6%. The company said $1.9 million of tariff refunds contributed 70 basis points.
SG&A was $30.7 million, down about $0.5 million year over year; it benefited from roughly $4.4 million in U.K. patent appeal recoveries and a separate settlement of about $1 million, partly offset by higher wages and benefits.
Aerospace sales were a record $245 million, and the segment ended the quarter with record backlog. Test Systems sales were $26 million, including $5.3 million from the Army radio test program.
Year-to-date sales were $762 million, up 22%; operating margin rose to 16% from 6.6% a year earlier, while adjusted EBITDA margin increased to 19.5% from 14.3%.

BFF Bank S.p.A.

BFF.MI Q3 2026

Reported: 2026-11-13

BFF Banking Group’s shares fell 22.7% after earnings, as investors focused on declining profit and negative capital generation amid balance-sheet derisking, higher provisions and legal costs. The outlook is pressured by management’s expectation of further increases in calendar provisioning in 2027 and 2028.

Key takeaways

Nine-month adjusted net profit fell 24% year on year to €90 million; net revenues declined 5%, and adjusted ROE fell to 19% from 27% in the first half.
Pretax profit dropped to €123 million from €161 million a year earlier, reflecting higher provisions, retrocessions and legal expenses, alongside lower risk-weighted assets.
Calendar provisioning increased by €96 million over the nine months—more than adjusted net profit—contributing to negative underlying capital generation. Management expects calendar provisioning to rise further in 2027 and 2028.
Factoring and Lending loans declined 13% as the group reduced exposure. Its lower volumes weighed on net interest income, though the IRR on new business rose to around 7% from 6% in Q2.
Securities Services and Payments remained comparatively supportive: Securities Services pretax profit rose €2.7 million, while Transaction Services fees grew, including an 8% increase in Securities Services commission income and 4% growth in Payments.

Boost Run Inc. Class A Common Stock

BRUN Q3 2026

Reported: 2026-11-13

Boost Run shares fell 19.8% after earnings, with the clearest likely concern being execution timing: a data-center delay pushed a project out of Q4 and reduced the company’s expected exit ARR by about $435 million versus what it otherwise would have been. The company also emphasized a large deployment ramp and substantial funding needs, leaving investors focused on delivery risk despite rapid revenue growth and new financing.

Key takeaways

Q3 revenue was $39.9 million, up approximately 496% year over year and 27% sequentially.
A data-center delay prevented one project from going live in Q4; management said the issue was resolved. Without the delay, exit ARR would have been approximately $435 million.
Boost Run reported $2.7 billion in total contract value, with about 26% expected to be live by the end of November 2026; the contracted projects are scheduled for deployment in 2027.
The company had $157 million in unrestricted cash at quarter-end and secured approximately $600 million in nondilutive project financing year to date. It also cited $482 million of customer prepayments due for upcoming deployments.
Management expects deployed colocation power capacity to reach approximately 40 megawatts by year-end 2026 and said it has secured 253 megawatts of accessible capacity for its 2027–2028 ramp.

Canaan Inc.

CAN Q3 2026

Reported: 2026-11-13

Canaan’s shares fell 11.0% after earnings, as investors appear to have focused on weak mining-hardware demand, elevated industry inventories and pressure on selling prices—not the longer-term potential of its energy and AI infrastructure pivot. Management also said it expects to substantially reduce new-product R&D spending, while the Duval County project remains in the grid-interconnection process and a potential strategic partnership is still under discussion.

Key takeaways

Management said bitcoin-mining hardware demand remains weak, inventories are elevated and selling prices are under pressure.
Higher wafer fabrication costs and tighter supply are making new mining machines harder to produce economically; Canaan said these conditions could constrain new-machine production and deployment over the next few years.
Several next-generation ASIC projects are complete or substantially complete, and initial engineering-sample results met design expectations. Canaan plans to reduce ongoing new-product R&D and retain the option to begin mass production when commercial conditions support it.
The 1 GW Duval County, Texas, project received a conditional Studied Load – Firm classification under ERCOT’s Batch 0 process; remaining interconnection procedures are ongoing.
Canaan is discussing a potential strategic partnership with a U.S. institution, but has not announced an agreement. A separate 1 GW project in Zapata County is at an early development stage.

Caledonia Investments plc

CLDN.L Q2 2027

Reported: 2026-11-13

Caledonia’s shares rose 5.7% after it reported a 5.4% first-half NAV total return and announced a 20p-per-share special dividend. The positive portfolio return was led by public companies, while Private Capital was nearly flat, partly due to weak demand for Cooke Optics’ established lenses.

Key takeaways

NAV total return was 5.4% for the half-year to 30 September 2026; the 10-year annualized return was 9.1%.
Public Companies returned 12.3% over six months. Caledonia invested £32m and realized £102m in the pool.
Private Capital returned 0.6%; gains from several holdings and Stonehage Fleming were largely offset by a lower Cooke Optics valuation.
Caledonia received £290m from the Stonehage Fleming sale, a 3.2x money multiple and 33% above its March 2025 carrying value.
It invested about £110m in Blue Diamond and Conquip, and announced a 20p special dividend alongside its 3.84p interim dividend.

CuriosityStream Inc.

CURI Q3 2026

Reported: 2026-11-13

Curiosity Stream’s shares rose 18.7% after the company reported higher revenue and earnings, with licensing—largely from AI developers—driving growth. Subscription revenue declined slightly, but management said subscription profitability improved significantly.

Key takeaways

Q3 revenue increased 13% year over year to $21 million, from $18.4 million.
Net income was $4.8 million, an $8.6 million improvement; adjusted EBITDA rose 67% to $5 million. EPS improved to $0.08 from a loss of $0.06.
Licensing revenue grew 35% to $11.7 million. Management said nearly all Q3 cash licensing revenue came directly from AI developers.
Subscription revenue declined slightly, though management reported significantly improved profitability and said it is prioritizing retention and lifetime value over growth at any cost.
Management cited an annualized cost structure below $40 million to operate the business and pay the annual dividend, and cautioned that licensing results can vary with the timing and size of individual transactions.

DATA Communications Management Corp.

DCM.TO Q3 2026

Reported: 2026-11-13

DCM’s shares rose 10.6% after the company reported a return to organic growth, with revenue up 8.2% and adjusted EBITDA up to $15.9 million. Higher gross margins and stronger year-to-date free cash flow added to the positive picture, though the quarter’s adjusted net income included several sizable adjustments.

Key takeaways

Revenue was $114 million, up 8.2% year over year; organic growth was 2.9%, with management reporting improvement in the underlying business from Q1 through Q3.
Gross profit increased 22.7% to $30.2 million. Gross margin expanded to 26.5% from 23.4%, reflecting improved core-business mix and Octacom’s higher-margin contribution.
Adjusted EBITDA rose to $15.9 million from $12.3 million, and its margin increased to 13.9% from 11.7%.
Year-to-date free cash flow was $15.5 million, versus $8.2 million a year earlier; cash from operations was $27.3 million, up from $16.8 million.
Adjusted net income was $1.3 million versus about $0.1 million a year ago. The company cited debt-modification charges, restructuring and integration costs, and net fair-value gains among its adjustments; it expects organic growth to continue in Q4.

Trump Media & Technology Group Corp.

DJT Q3 2026

Reported: 2026-11-13

Trump Media rose 5.4% after reporting 205% year-over-year revenue growth to about $3 million and sharply lower legal expenses. The quarter’s $409.7 million net income was driven almost entirely by mark-to-market gains on digital assets, so it is not a clean measure of operating performance.

Key takeaways

Revenue increased 78% sequentially, primarily from Truth API and Truth Plus subscriptions, higher Truth Social advertising, and Truth.Fi ETF management fees.
Operating expenses, excluding digital-asset gains and losses, were $26.5 million, down 45% sequentially and 37% year over year. Legal fees fell to $2.4 million from more than $20 million in the second quarter.
Net income was $409.7 million; management said the increase was driven almost entirely by digital-asset and related securities mark-to-market gains. The company reported approximately 15,600 Bitcoin holdings, with roughly 11,400 pledged to its Bitcoin yield program.
Trump Media reported $2.5 billion in total assets, including $2.3 billion in financial assets, and said it intends to use cash and available credit to address bond obligations and its capital structure.
The company said its merger with TAE Technologies remains on track to close by year-end; the shareholder meeting is scheduled for December 14.

Dream Unlimited Corp.

DRM.TO Q3 2026

Reported: 2026-11-13

Dream shares rose 9.6% after earnings, with asset management growth and higher income-property NOI driving a year-over-year increase in quarterly net margin. Management also cited $100 million of Western Canada revenue secured for Q4, while noting weaker activity in Toronto development and a sales mix that weighed on Western Canada’s Q3 margin.

Key takeaways

Stand-alone net margin rose to $32.6 million from $24.1 million; after-tax earnings were $13.1 million. Management expects Q4 margin to be its strongest of the year.
Asset Management delivered $23.2 million of revenue and $17.8 million of net margin, up $6.8 million from a year earlier. AUM stood at $31 billion, including post-quarter acquisitions.
Western Canada development generated $8.9 million of Q3 net margin, modestly below the prior year due to sales mix and volumes. Presales commitments support $100 million of Q4 revenue.
Income-property NOI increased to $7.6 million from $6.5 million, largely on apartment lease-up; results included a $550,000 bad-debt expense.
The company reported $264 million of available corporate-facility liquidity and about $596 million of current debt. Approximately $205 million matures in Q1 2027, with refinancing discussions underway.

Discovery Silver Corp.

DSV.TO Q3 2026

Reported: 2026-11-13

Shares fell 8.8% after earnings, despite record revenue and EBITDA, as higher costs and accelerating investment weighed on the quarter’s cash generation. Cash costs rose to $1,470 per ounce sold and AISC to $2,293, while capital spending reached $116 million.

Key takeaways

Revenue rose 16% quarter over quarter to a record $371 million, reflecting 8% more ounces sold at Porcupine and a full quarter of Kidd operations.
EBITDA increased 7% sequentially to a record $181 million; year-to-date EBITDA was $529 million, versus $171 million in the same period last year.
Free cash flow was $87 million, up from an $11 million outflow in Q2, but cash capital spending climbed to $116 million.
Higher royalties and processing higher-cost inventory contributed to cash costs of $1,470 per ounce; AISC was $2,293 per ounce, including higher sustaining investment.
Cash increased 24% to $450 million at September 30. Management also cited key Cordero permits received and exploration potential at Pamour and Dome as growth priorities.

EuroDry Ltd.

EDRY Q3 2026

Reported: 2026-11-13

EuroDry reported third-quarter net income of $6.86 million, or $2.39 per diluted share, and the stock rose 8.6% after earnings. The quarter’s year-over-year dry-bulk market gains and Ultramax rate strength are positives, though recent Panamax spot and time-charter rates had softened.

Key takeaways

Q3 revenue was $19.4 million; adjusted net income was $6.67 million, or $2.32 per diluted share, and adjusted EBITDA was $11.34 million.
The Baltic Dry Index rose about 65% year over year in Q3 and the Baltic Panamax Index rose about 42%. Ultramax spot rates increased from a Q3 average of $23,500/day to $25,500/day as of November 6.
Rate trends were mixed: Panamax spot rates eased from a Q3 average of $18,000/day to $17,200/day, while one-year Panamax time-charter rates declined from $18,100/day to $16,875/day.
EuroDry operates 11 vessels and has five newbuildings scheduled for delivery in 2027–2029; upon delivery, the fleet is expected to expand to 16 vessels.
The company raised approximately $10.7 million through its at-the-market equity program, issuing 163,753 shares at an average price of $67.54; it also reported a $556,000 loss on two previously agreed FFAs.

Siemens Energy AG

ENR.DE Q4 2026

Reported: 2026-11-13

Shares rose 10.6% after Siemens Energy reported a record year, with full-year pre-special-items margin of 12.4% and pre-tax free cash flow of €8.8 billion. The positive reaction also reflects its forward plan to expand production capacity by more than 50% by fiscal 2030.

Key takeaways

Q4 comparable revenue reached a record €12.8 billion, up 21%; profit before special items more than tripled to €1.5 billion, a 12% margin.
For fiscal 2026, comparable revenue grew 15.5%, net income was €4.1 billion, and the pre-special-items margin improved by 640 basis points year over year.
Pre-tax free cash flow rose to €8.8 billion for the year, up €4.1 billion; the order backlog grew by €26 billion.
Siemens Gamesa delivered its second consecutive profitable quarter and broke even for the full year.
Management plans to increase capacity in gas turbines, power transformers, and gas-insulated switchgear by more than 50% by fiscal 2030; 96% of fiscal 2026 CapEx projects were within budget and progressing as planned.

E.ON SE

EOAN.DE Q3 2026

Reported: 2026-11-13

The stock was unchanged after earnings, reflecting a broadly in-line update: adjusted EBITDA was stable and the company reaffirmed its guidance. Rising financing costs and continued investment remain pressures, while the company said a temporary accounting effect affected reported net debt.

Key takeaways

Nine-month adjusted EBITDA was €7.1 billion, broadly stable year over year; adjusted net income rose 4% to €2.2 billion.
Energy Networks earnings were stable, while Energy Infrastructure Solutions EBITDA grew 15%; Energy Retail performance was in line with expectations.
The company reaffirmed 2026 guidance and expects around €8.7 billion of full-year investment; its CapEx fill rate was around 60% after nine months.
Excluding a temporary noncash accounting effect, economic net debt was €46.1 billion at Q3-end, down from €46.5 billion at Q2-end. The company said the effect would largely unwind during 2027.
Financing expenses increased due to higher net debt and refinancing costs, and the company expects the rising interest effect to continue in Q4 and beyond.

FLEX LNG Ltd.

FLNG Q3 2026

Reported: 2026-11-13

Flex LNG’s shares rose 2.1%, a broadly neutral reaction. The quarter included record revenue, but management expects full-year results in the mid-to-lower end of its existing guidance and flagged a soft spot market and increased vessel exposure to spot.

Key takeaways

Q3 revenue was $97.4 million ($95.2 million excluding EUAs); net income was $42.8 million, or $0.79 per share. Adjusted net income was $35.0 million, or $0.65 per share.
Fleet-average TCE was close to $79,000 per day. Revenue decreased from Q2, mainly because Flex Volunteer had earned a higher spot rate for much of the prior quarter.
Full-year guidance was maintained: revenue of $345 million–$370 million, TCE of $73,000–$78,000 per day, and adjusted EBITDA of $255 million–$280 million. Management expects results toward the mid-to-lower end of those ranges.
Full-year OPEX guidance increased from $16,000 to $16,200 per day, with management citing, among other factors, higher travel and crew-change costs related to the Middle East conflict.
The board declared another $0.75-per-share dividend. Flex LNG ended Q3 with $371 million in cash and 48 years of minimum firm backlog, though it flagged a soft spot market, next year’s newbuild deliveries, and greater spot exposure.

Forgent Power Solutions, Inc.

FPS Q1 2027

Reported: 2026-11-13

Forgent shares fell 9.8% after earnings. The transcript ends before management provides first-quarter results or its updated outlook, so it does not identify a specific earnings or guidance disappointment; the most visible risk discussed is that regulation could delay or relocate data-center projects.

Key takeaways

Management said customer conversations had not changed expectations for how much data-center capacity will ultimately be needed, though regulation could affect where, when, and how projects are built.
The company cited industry forecasts for more than 100 GW of incremental U.S. data-center capacity from 2027–2031; in its illustrative scenario, a 20% reduction would still leave roughly 80 GW over five years.
Management said demand for medium-voltage switchgear, transformers, and other critical electrical equipment materially exceeds available industry capacity.
Forgent said its backlog extends through fiscal 2027 and into fiscal 2028; a “good portion” is supported by nonrefundable deposits, and purchase orders generally arrive after permitting is complete.
The supplied transcript cuts off before quarterly financial results and the updated outlook are presented, so revenue, margins, and guidance cannot be assessed from this excerpt.

Gevo, Inc.

GEVO Q3 2026

Reported: 2026-11-13

Gevo shares rose 30.9% after the company reported record third-quarter revenue, net income, adjusted EBITDA and operating cash flow, and said 2026 adjusted EBITDA could exceed $90 million. The positive reaction aligns with the reported profitability and cash generation, though the outlook includes one-time carbon-credit revenue and anticipated RNG tax-credit value.

Key takeaways

Third-quarter revenue was $83 million, gross profit $48 million, adjusted EBITDA $44 million, and cash flow from operations $41 million; quarter-end cash was $68 million.
Gevo expects more than $50 million of carbon revenue in 2026. Third-quarter revenue included $20 million from previously banked Canada CFR credits and $10 million of additional CFR credit revenue; the company estimates a $30 million annual carbon revenue run rate excluding one-time items.
The company said full-year 2026 adjusted EBITDA could exceed $90 million, including the approximately $20 million of previously banked CFR credits recognized in Q3 and about $10 million of anticipated additional 45Z value from existing RNG assets, subject to third-party validation.
Gevo said it had sold $70 million of 45Z credits through Q3. It expects the revised 45Z-GREET model to add more than $10 million of value from existing RNG assets in 2026.
Growth initiatives include Praj’s construction of an isobutanol demonstration plant in India and Gevo’s evaluation of an expansion in specialty fuels using equipment it already owns.

GrainCorp Limited

GNC.AX Q4 2026

Reported: 2026-11-13

GrainCorp delivered FY26 underlying EBITDA of $223 million, in line with its guidance, against a backdrop of surplus global grain and below-average margin opportunities. The shares rose 2.0% after the results, a roughly flat reaction.

Key takeaways

Closing core cash was $171 million; the Board declared a fully franked full-year dividend of $0.28 per share.
GrainCorp reported $12 million in early-stage run-rate benefits from its group-wide transformation program and said underlying corporate costs remained steady despite inflation.
Crush throughput remained above 550,000 tonnes, bulk materials handled reached 3.1 million tonnes, and Animal Nutrition sales volumes increased.
Management cited surplus global grain production, lower commodity prices and reduced grower willingness to sell as factors behind below-average margin opportunities in FY26.
FY27 harvest activity is accelerating, supported by recent rainfall; management said this should benefit summer crop planting in northern regions and finishing yields in the south.

GrowGeneration Corp.

GRWG Q3 2026

Reported: 2026-11-13

GrowGeneration’s shares fell 19.7% after it withdrew full-year adjusted EBITDA guidance, citing further store closures and restructuring that introduce near-term uncertainty. Revenue guidance was narrowed, while management said the actions are intended to lower costs and improve profitability in 2027.

Key takeaways

Q3 net sales were $44.8 million, gross margin was 32.4%, and adjusted EBITDA was $2.3 million.
Full-year revenue guidance was refined to $163 million–$165 million from $162 million–$168 million; the company withdrew its full-year adjusted EBITDA guidance.
Proprietary brand sales rose approximately 19% year over year to $14.5 million, surpassing 40% of cultivation and gardening net revenue.
Store and other operating expenses declined approximately 12% year over year to $6.4 million. GrowGeneration expects to close another 4–5 locations in Q4 as part of its restructuring.
MMI storage solutions generated $9.2 million in Q3 revenue, ahead of management’s expectations. The company ended the quarter with $41.8 million in cash, cash equivalents and marketable securities, no debt, and repurchased 700,000 shares for $1 million.

Himalaya Shipping Ltd.

HSHP Q3 2026

Reported: 2026-11-13

Himalaya Shipping reported higher year-over-year earnings, while the shares rose 1.3% after the results—a roughly flat reaction. Results included a $58,400 daily TCE and $0.75 per share in quarterly distributions; the company also reported October TCE of about $50,900 per day.

Key takeaways

Q3 net profit was $33.3 million, or $0.71 per share, versus $9.5 million, or $0.21 per share, in Q3 2025. EBITDA increased to $52.7 million from $29.3 million.
Revenue rose to $62.6 million from $37.9 million, alongside daily TCE increasing to $58,400 from $35,600.
Operating expenses were $7.5 million, up $0.5 million year over year; G&A rose to $1.5 million from $1.1 million, partly reflecting consolidation of Peak Maritime Management.
Cash and equivalents were $39.7 million at quarter-end, against a $12.3 million minimum cash requirement under sale-leaseback financing. The financing balance was about $681 million.
The company declared $0.75 per share in distributions for July–September and reported October TCE of about $50,900 per day.

Humacyte Inc. Common Stock

HUMA Q3 2026

Reported: 2026-11-13

Humacyte’s stock rose 29.6% after Symvess sales more than doubled quarter over quarter, hospital adoption expanded, and management forecast at least a doubling of Q4 sales. The positive reaction also reflects progress toward the dialysis-access filing and the start of a Phase 2a CABG study.

Key takeaways

Q3 Symvess sales were slightly over $1 million, up 151% from Q2 and above the company’s internal goal.
Hospitals ordering Symvess increased 44%, from 34 at the end of Q2 to 49 at September 30.
October sales reached $800,000; management expects Q4 sales to at least double Q3 and anticipates at least 20 additional hospitals able to order by year-end.
The supplemental BLA for ATEV in dialysis access is on track for submission later this month, supported by results from three Phase 3 studies.
Humacyte has initiated its first Phase 2a CTEV study in CABG and is screening patients.

SeaStar Medical Holding Corporation Common Stock

ICU Q3 2026

Reported: 2026-11-13

SeaStar Medical shares fell 44.7% after earnings, with the clearest disappointment being a delay in the NEUTRALIZE-AKI trial: enrollment is now expected to finish by mid-2027. QUELIMMUNE sales grew sharply, but that progress was overshadowed by the slower timeline for the pivotal adult AKI study.

Key takeaways

NEUTRALIZE-AKI has enrolled about 75% of its planned 339 patients; management now expects enrollment completion by mid-2027, citing strict eligibility criteria and a cautious outlook.
QUELIMMUNE revenue was over $630,000 in Q3, up 247% year over year. Nine-month revenue reached $1.7 million, and management expects to exceed its $2 million full-year revenue guidance.
Twenty of the 50 targeted pediatric medical centers are current customers; SeaStar has added 10 new customers so far in 2026.
The FDA confirmed SeaStar met requirements for the mandatory SAVE post-approval registry, and CMS assigned ICD-10-PCS codes for procedures using QUELIMMUNE.
SeaStar received FDA Breakthrough Device Designation for its SCD therapy for hyperinflammation in adults with sepsis and has submitted the first module of the adult AKI PMA.

Infineon Technologies AG

IFX.DE Q4 2026

Reported: 2026-11-13

Infineon’s shares rose 7.2% after the company forecast fiscal 2027 revenue of around €20 billion, up more than 20% year on year, and a mid-20s segment result margin. The outlook builds on a fiscal 2026 recovery, though it also entails €3–3.5 billion of fab investment.

Key takeaways

Fiscal 2026 revenue was €16.353 billion, up around 12% year on year, or 15% at constant exchange rates; the fourth quarter was a record.
The segment result margin improved to 19.7% from 17.5% in the prior year.
Adjusted free cash flow was €1.9 billion, equal to 11.8% of revenue; the company said this was in line with its target operating model.
For fiscal 2027, Infineon expects around €20 billion in revenue and a mid-20s segment result margin.
Planned fiscal 2027 investment is €3–3.5 billion in fabs, plus around €2.8 billion for research and development.

MiNK Therapeutics Inc. Common Stock

INKT Q3 2026

Reported: 2026-11-13

MiNK shares fell 4.8% after earnings, likely reflecting the long wait for comparative evidence: the ARDS trial’s readout is expected in 2027, while U.S. dosing has not yet begun and remains targeted for before year-end. Early patient observations were encouraging but small and uncontrolled, and the pivotal-development path still depends on FDA discussions.

Key takeaways

The randomized Phase II ARDS study continued enrolling in Ukraine; U.S. activation is in its final stages, with dosing expected to begin before year-end.
The company expects a comparative readout in 2027. It plans an initial randomized stage of about 124 patients, potentially expanding to as many as 300, and aims to discuss the design with the FDA before year-end.
Management reported no major serious adverse events attributed to agenT-797 in the patients discussed. Clinicians also described improvements in fever, oxygenation and ventilator use, while emphasizing the observations involve small numbers and no comparator.
MiNK recognized its first pre-commercial revenue from agenT-797 supplied through a paid named-patient access program in multiple countries outside the U.S.; the transcript did not disclose revenue.
Management estimates about 93,000 U.S. patients annually in its initial target population of ventilated patients with pneumonia-associated moderate-to-severe ARDS.

Jones Soda Co.

JSDA Q3 2026

Reported: 2026-11-13

Jones Soda’s shares rose 13.6% after it reported record third-quarter revenue of $13.7 million, positive net income and adjusted EBITDA, and improved gross margin. It affirmed its full-year outlook, though the quarter’s growth was substantially driven by Fallout products and about $2 million of shipments shifted from Q2.

Key takeaways

Revenue increased 204% year over year to $13.7 million, from $4.5 million; management said Fallout club-channel sales and the shifted shipments were the primary drivers.
Gross margin rose to 34.4%, up from 28.9% a year earlier and 27.5% in Q2, supported by lower freight rates, scale and sales mix.
The company reported $471,000 of net income from continuing operations and $869,000 of adjusted EBITDA, a $1.77 million improvement from the prior-year quarter.
Jones reaffirmed its 2026 outlook for revenue above $45 million—growth of more than 80%—and positive adjusted EBITDA.
Management expects D2C revenue to reach approximately $5 million this year, versus about $1 million last year; it also said the initial Fallout rocket-bottle release sold out within a week.

Kemper Corporation

KMPR Q3 2026

Reported: 2026-11-13

Kemper shares rose 3.7% after earnings. Investors may have welcomed improved auto underwriting trends, though personal auto remains unprofitable and the company expects lower premium and policy counts as it prioritizes margins.

Key takeaways

Personal auto’s underlying combined ratio improved by nearly 8 points since the first quarter; California’s improved by more than 7 points. Kemper said it is still not earning an underwriting profit in personal auto.
The margin gains came with declines in personal auto premiums and policy counts. Management’s next focus is stabilizing production and returning to growth at a pace justified by profitability.
In commercial auto, margins narrowed and new business growth slowed as expected after the company prioritized rate and tighter underwriting; management said it will accept modest growth while working toward its targets.
Net income was $52.4 million, or $0.88 per diluted share, and adjusted consolidated net operating income was $59.9 million, or $1.01 per diluted share.
Kemper plans structured tests across lead generation, management and fulfillment to identify distribution tactics to scale or stop.

Kura Oncology, Inc.

KURA Q3 2026

Reported: 2026-11-13

Kura reported continued commercial growth for COMZIFTI and progress on darlafarnib, with the stock up 2.1% after earnings—a roughly flat reaction. The update included positive launch metrics, but the transcript provided no new full-year revenue guidance or complete clinical data to assess the broader outlook.

Key takeaways

COMZIFTI third-quarter net product revenue was $13.9 million, up 53% sequentially; new patient starts rose about 30% to approximately 150.
Total prescriptions increased 65% to more than 2,400, and 170 accounts had prescribed COMZIFTI, up 40% quarter over quarter. Kura said it maintained a majority share of menin-inhibitor new patient starts in the approved setting.
Kura said it aligned with FDA on a single-arm monotherapy registrational study of darlafarnib in HRAS-mutant salivary gland cancer.
Eight Ziftomenib abstracts are planned for ASH, including first clinical data on combinations with FLT3 inhibitors; the call excerpt did not provide the data or resulting development decisions.
Management cited a strategic financing agreement with OrbiMed as providing flexibility to fund key milestones, but gave no specific funding outlook figures in the excerpt.

Lucid Group Inc. Common Stock

LCID Q3 2026

Reported: 2026-11-13

Lucid shares rose 4.7% after the company reported a 30% sequential reduction in free cash outflow and said it remains on track for its $1.4 billion 2026 cash-flow improvement target. The progress was paired with $1.75 billion in added liquidity from its largest investor, though the call also emphasized that substantial work remains.

Key takeaways

Free cash outflow fell 30% from Q2; management said actions underway keep the company on track for its $1.4 billion cash-flow improvement target for 2026.
Lucid said its largest investor increased the credit facility, adding $1.75 billion of liquidity.
Customer metrics improved: web leads are up 79% since January, session-to-order conversion doubled, and cost per order fell 82%.
Service wait times declined around 20%, while warranty claims fell 70% in Q3 and warranty costs were 16% lower year over year.
Management said the Uber and Nuro robotaxi program is progressing as planned, AMP-2 is moving toward production readiness, and Midsize is on track; it also acknowledged significant work remains.

NEXON Co., Ltd.

NEXOY Q3 2026

Reported: 2026-11-13

NEXON’s Q3 results were above its outlook, led by MapleStory and FC, while the stock was essentially flat at -0.1%. Dungeon & Fighter fell short of expectations and is expected to decline year over year in Q4, tempering the upbeat results elsewhere.

Key takeaways

Q3 revenue was JPY 138.4 billion, up 17% year over year; operating income was JPY 41.8 billion, up 11% and close to 30% above the high end of the company’s outlook.
MapleStory revenue grew 72% year over year to a quarterly record, supported by MapleStory Classic in China, the core PC game in Korea, and newer experiences.
FC returned to year-over-year growth, led by FC ONLINE, where average play time reached a record high.
Dungeon & Fighter declined year over year and missed the company’s outlook after China’s September update fell short; management expects Q4 revenue to decline year over year.
Costs were below plan despite higher royalties, and headcount was essentially flat year over year. NEXON said its project review process canceled six projects this year and redirected people and budgets to other games.

National Health Investors, Inc.

NHI Q3 2026

Reported: 2026-11-13

NHI shares fell 4.8% after the company said third-quarter SHOP performance fell short of expectations: weaker-than-expected contributions from non-same-store communities offset 19.5% year-over-year NOI growth at same-store properties. Management said it is addressing operating performance with partners, but the shortfall puts execution of its SHOP growth strategy in focus.

Key takeaways

The 15 same-store SHOP properties delivered approximately 19.5% year-over-year NOI growth, in line with NHI’s outlook; non-same-store communities contributed less than expected.
NHI completed $396.2 million of investments year-to-date at an average 7.5% yield, including $320 million of SHOP investments at a 7.3% average year-one yield after routine CapEx.
The company expects about $190 million of signed-LOI investments to close in the fourth quarter, bringing projected 2026 investment to approximately $590 million. Expected year-end acquisitions will initially be net leased, with anticipated SHOP conversions in 2027.
SHOP’s share of total NOI rose to approximately 18%, from 9% entering the year, including an October acquisition. Management reiterated its target of high-single-digit to low-double-digit organic SHOP NOI growth.
NHI said leverage is below 3x and expects to recycle more than 95% of the NHC sale proceeds before year-end; the sale generated $555 million in net proceeds.

Verde Agritech Plc

NPK.TO Q3 2026

Reported: 2026-11-13

Verde AgriTech’s shares were unchanged after earnings. Results showed sharply lower sales and volume, while management is targeting roughly breakeven EBITDA or cash flow over the next 12 months rather than near-term growth.

Key takeaways

Q3 revenue fell to CAD 3.5 million from CAD 5.9 million a year earlier; sales volume declined to 40,000 tons from 85,000.
Gross profit per ton was CAD 23, versus CAD 25 last year. Excluding freight, gross margin fell to 46% from 60%, which management attributed largely to lower volume.
Cash EBITDA was negative CAD 700,000, compared with positive CAD 200,000 a year earlier. Net loss widened to CAD 3.1 million from CAD 2.1 million.
SG&A declined about 11% year over year. Management plans a CAD 3 million cost-saving program for next year and expects further expense improvements from Q1.
The company reported CAD 4.7 million in cash and CAD 4.1 million in trade and other receivables at September 2026.

Energy Vault Holdings, Inc.

NRGV Q3 2026

Reported: 2026-11-13

Energy Vault shares rose 9.6% after the company raised its 2026 revenue outlook to the top half of its prior range and introduced 2027 guidance calling for revenue to more than double and EBITDA to turn positive. The outlook is ambitious, with management emphasizing execution on a roughly $250 million fourth quarter and delivery of healthy margins and cash conversion.

Key takeaways

2026 revenue guidance was revised to $290 million–$310 million, which management said is in the top half of its previous range; it expects roughly $250 million of revenue in Q4.
For 2027, the company forecast revenue of $600 million–$700 million and EBITDA of $40 million–$50 million, describing it as its first full year of positive EBITDA.
Backlog increased about 15% sequentially, according to management, supporting revenue visibility into the remainder of 2026 and 2027.
Cash totaled $236 million at quarter-end, up roughly 60% sequentially and nearly threefold year over year; corporate-level recourse debt fell by $12 million during the quarter.
The Goshe acquisition added 2.3 GW of U.S. battery-storage development projects, including 350 MW described as ready to build.

Occidental Petroleum Corporatio

OXY Q3 2026

Reported: 2026-11-13

Occidental’s shares rose 2.0% after earnings, a roughly flat reaction. The company reported production above the midpoint of guidance and progress on debt reduction, while Gulf of America output faced a third-party pipeline constraint and maintenance.

Key takeaways

Total company production exceeded the midpoint of guidance; U.S. onshore production was 20,000 BOE per day above its midpoint.
Midstream delivered more than $300 million in adjusted pretax income, and Occidental reached its $10 billion principal debt milestone.
New Mexico gross operated production hit a record 284,000 BOE per day, up about 23% since January; Powder River Basin production averaged 23,000 BOE per day, more than 70% above the first quarter.
Gulf of America production was affected by a third-party gas pipeline constraint and maintenance.
Management outlined a target to add more than $4 billion of annual sustainable cash flow by 2030, driven by cost efficiencies, lower decline rates and lower debt interest.

Rigetti Computing Inc. Common Stock

RGTI Q3 2026

Reported: 2026-11-13

Rigetti shares fell 8.6% after earnings, with the likely pressure coming from an ambitious technology road map that still places its next major system target in mid-2028, rather than near-term commercial milestones. The quarter included a 99.5% median two-qubit gate-fidelity result on its 108-qubit system and a $100 million Commerce Department agreement, but the transcript provides limited near-term financial or deployment detail.

Key takeaways

Cepheus-1 108Q reached 99.5% median two-qubit gate fidelity; the company also reported 99.6% on an 80-qubit sublattice and 99.7% on a 50-qubit sublattice.
The system continues to operate at approximately 99.9% median single-qubit fidelity and approximately 60-nanosecond gate speeds.
Rigetti signed a definitive agreement with the U.S. Department of Commerce for $100 million to support research and development in three areas tied to scaling superconducting quantum computing.
The next major target is a 300-plus-qubit system with approximately 99.7% median two-qubit gate fidelity and sub-60-nanosecond gate speeds by mid-2028; a roughly 1,000-qubit system is targeted in about three years.
Management said coherence times of approximately 25–30 microseconds were the primary constraint on further fidelity improvement, highlighting a technical challenge still to overcome.

Riskified Ltd.

RSKD Q3 2026

Reported: 2026-11-13

Riskified’s shares rose 11.1% after the company reported 41% revenue growth to $115.2 million, well ahead of its approximately 27% growth outlook, and raised its full-year revenue and adjusted EBITDA outlook for the third time this year.

Key takeaways

Q3 revenue increased 41% year over year to $115.2 million, the company’s first quarter above $100 million.
Adjusted EBITDA was $8.1 million; non-GAAP gross profit grew 20% to $49.7 million.
Management cited broad-based growth across verticals, led by digital finance, and execution in both new business and expansion of the existing customer base.
Riskified announced agent identity risk intelligence and a Zendesk integration, extending its risk and identity capabilities to AI-assisted shopping and customer-service requests.
The transcript provided does not specify the revised full-year outlook figures.

K+S Aktiengesellschaft

SDF.DE Q3 2026

Reported: 2026-11-13

K+S shares fell 5.5% despite the company saying Q3 was in line with expectations and slightly lifting the midpoint of full-year EBITDA guidance. The narrower outlook still leaves meaningful sensitivity to winter weather, selling prices and energy and logistics costs, while higher costs and Bethune maintenance weighed on the quarter.

Key takeaways

Q3 EBITDA was €108 million, versus €111 million a year earlier; higher selling prices and de-icing salt pre-buying were offset by increased logistics and energy costs and the Bethune shutdown.
Full-year 2026 EBITDA guidance is now €700–750 million, versus €680–760 million previously. The company raised the lower end by €20 million but trimmed the upper end by €10 million; the midpoint is in line with Vara consensus.
Adjusted free cash flow was €18 million. The company maintained its mid- to high-double-digit-million-euro full-year free cash flow guidance and €580–600 million CapEx outlook.
K+S said geopolitical factors have elevated costs and expects some effects, particularly on freight, to persist into 2027. It has hedged 50% of its energy requirements.
Bethune is producing about 2.3 million tonnes annually; management expects gradual annual increases of 100,000–150,000 tonnes, with output around 2.4–2.5 million tonnes by end-2027 depending on winter conditions.

Sky Harbour Group Corporation

SKYH Q3 2026

Reported: 2026-11-13

Sky Harbour shares rose 6.2% after earnings, with revenue growth and accelerating construction likely supporting the positive reaction. The quarter also showed a near-term profitability drag: operating expenses increased ahead of new campus openings, and adjusted EBITDA remained negative at approximately $5 million.

Key takeaways

Consolidated Q3 revenue increased 45% year over year and 7% sequentially, driven by new campus openings, higher occupancy, and rental rates.
Assets under construction and completed construction reached $439 million, up $111 million year to date; the company said construction activity was at a record pace.
Operating expenses continued to rise ahead of new campus openings, including campus headcount and lease expense for sites not yet operating. Management expects margins to expand as campuses stabilize.
Adjusted EBITDA was approximately negative $5 million, improving on higher operating margins at open campuses and slightly lower corporate overhead.
Operating cash flow was slightly negative in Q3, which management attributed to a one-time payment of almost $1 million in accrued Yorkville loan interest; the obligated group generated $3.2 million of operating cash flow.

Swiss Life Holding AG

SLHN.SW Q3 2026

Reported: 2026-11-13

Swiss Life shares slipped 0.6%, a roughly flat reaction to a mixed nine-month update. Fee income grew, but third-party asset-management net new assets fell from an unusually high prior-year level, and the estimated SST ratio was about 10 percentage points below June.

Key takeaways

Group fee and commission income rose 8% in local currency to more than CHF 2 billion; gross written premiums increased 8% to CHF 17.4 billion.
Switzerland premiums grew 15% to CHF 9.4 billion, while France premiums rose 4%, below the market’s 6% growth.
Third-party asset-management net new assets were CHF 8.5 billion versus CHF 15 billion in the prior-year period; assets under management rose to CHF 161 billion from CHF 146 billion at year-end 2025.
Net investment income increased to CHF 3.4 billion, supported by net capital gains, while direct investment income was CHF 0.17 billion lower year over year.
The estimated SST ratio was around 205% at September-end, approximately 10 percentage points below June.

Sonos, Inc.

SONO Q4 2026

Reported: 2026-11-13

Sonos shares rose 12.8% after earnings. The company reported a return to growth, including double-digit growth in Q4, and said profitability stepped up significantly.

Key takeaways

CEO Thomas Conrad said Sonos returned to growth in fiscal 2026 and delivered double-digit growth in Q4; he also cited a significant increase in profitability.
Sonos brought five products to market during the fiscal year: Sonos Play, Era 100 SL, Amp Multi, Beam Ultra, and Ace Ultra.
62% of Sonos households own more than one product, and 44% of this year’s registrations came from homes that already owned Sonos.
Amp Multi began shipping August 25; Beam Ultra and Ace Ultra reached customers ahead of the holidays. The transcript cites positive installer response and favorable product reviews.
Sonos 27 introduces an annual fall release cadence. Sonos Voice and Sonos MCP are in early access.

Swarmer, Inc Common Stock

SWMR Q3 2026

Reported: 2026-11-13

Swarmer’s shares rose 7.5% after the company outlined a shift toward selling complete defense systems and reported rapid growth at its pending Ratel acquisition. The market’s positive reaction comes alongside substantial potential revenue, but much of it depends on transactions, production plans and targets that are not yet fully secured.

Key takeaways

Swarmer ended Q3 with more than $37 million in cash, up from approximately $25 million in Q2.
Ratel reported unaudited year-to-date 2026 revenue of $42.1 million, including $32.5 million in Q3. Swarmer expects the acquisition to close in November and estimates Ratel Q4 revenue of $35 million–$40 million, with operating margins of 13%–17%.
Ratel has $86 million of previously signed government contracts. Its acquisition agreement sets revenue targets of $77 million in 2026, $130 million in 2027 and $187 million in 2028, with consideration largely contingent on performance.
Under an MOU, Vectus has indicated it intends to buy at least 40 air defense systems in the first year of production and 80 or more in the second, subject to definitive agreements and approvals. Estimated MSRP is $5 million–$6 million per system.
Swarmer expects its strategy to tilt toward direct government sales and hardware, with B2B software becoming one of several revenue streams. The company said its Q3 results do not yet reflect Ratel’s revenue.

Tidewater Inc.

TDW Q3 2026

Reported: 2026-11-13

Tidewater’s shares rose 4.1% after earnings, as investors responded to a third consecutive quarter of higher leading-edge day rates and revenue above expectations. Management also forecast revenue, gross-margin, and cash-flow growth into 2027 as the fleet rolls onto higher-rate contracts.

Key takeaways

Leading-edge day rates rose more than 12% sequentially to just over $27,000 per day; year to date, they were up about $4,900 per day.
Revenue was $360.4 million, including one month of Wilson Sons, and was ahead of expectations. Gross margin was just under 47%, nearly one point above prior guidance, and approximately 48% excluding Epic Fury-related costs.
Free cash flow increased more than 40% to $91 million, mainly on better collections and lower capital expenditure. Management expects it to improve again in the fourth quarter.
Wilson Sons closed on September 1; management expects integration onto Tidewater’s platform by early 2027. The combined company ended the quarter with net leverage below 0.9x and approximately $650 million of liquidity.
Tidewater repurchased $25 million of shares after the acquisition closed, leaving about $475 million under its $500 million authorization. Conflict-related costs are expected to ease to about $5 million in the fourth quarter, from $5.6 million in the third.

T1 Energy Inc

TE Q3 2026

Reported: 2026-11-13

T1 shares fell 7.5% after earnings, with the transcript pointing to the still-unclosed, primarily debt-based financing for G2_Austin Phase 1 as a key source of investor disappointment. Management says that financing remains the company’s top priority, while the near-term buildout and hiring are weighing on financial performance.

Key takeaways

T1 is negotiating with institutional investors under exclusivity, with certain exceptions, for a financing solution; it did not announce a completed deal.
The company announced nearly 1.6 GW of new offtake contracts in October, bringing contracted 2027 capacity to more than 3.5 GW.
T1 received a Section 232 waiver allowing up to 1.725 GW of solar cell imports to support G1_Dallas production while G2_Austin advances.
At G2_Austin, the external steel structure is complete, all Phase 1 equipment has arrived at U.S. ports, and mechanical, electrical, and plumbing installation has begun.
Management said building G1 inventory for 2027 contracts and higher SG&A from hiring are dampening near-term financial performance.

TAG Immobilien AG

TEG.DE Q3 2026

Reported: 2026-11-13

TAG Immobilien shares fell 4.7% after earnings, despite higher 2026 FFO I guidance, as investors may have focused on the 2027 outlook: FFO II is expected to decline roughly 9%, and net income from Polish sales roughly 40%, partly because TAG will recognize a smaller share of ROBYG’s results. Higher financing costs are also expected to reduce 2027 guidance by about EUR 10 million.

Key takeaways

FFO I rose 12% year on year in the first nine months; TAG raised its 2026 guidance, which implies roughly 9% annual growth.
For 2027, TAG expects FFO I of EUR 200 million–EUR 210 million, around 4% growth; rental-business EBITDA is forecast to increase by roughly 8%.
Polish sales net income was EUR 29.6 million for the first nine months, versus EUR 34 million a year earlier. TAG expects roughly 40% lower Polish sales income in 2027 as it accounts for 67% of ROBYG after the IPO.
ROBYG’s IPO generated EUR 282 million in gross proceeds for the group and reduced LTV to 42.6%, about 300 basis points below the prior quarter; it also added roughly EUR 62 million to EPRA NTA.
TAG expects broadly stable German portfolio valuation for full-year 2026, with a slight loss in the second half; Polish portfolio valuation is expected to be broadly unchanged in H2.

UniCredit S.p.A.

UCG.MI Q3 2026

Reported: 2026-11-13

UniCredit’s shares rose 8.8% after the company reported 12% third-quarter revenue growth, a 24% increase in net profit and raised its 2026 net profit expectation to well above €11.5 billion before extraordinary charges. The higher outlook, alongside accelerating core revenue and strong capital generation, appears to have been the key positive signal.

Key takeaways

Third-quarter revenue rose 12% year over year; core revenue increased 9% and accounted for more than 90% of total revenue.
Net profit increased 24% to €3.3 billion, while return on tangible equity reached 25.5%.
Costs fell 1%, bringing the cost-income ratio to a record-low 32.8%; cost of risk was 18 basis points.
Nine-month organic capital generation was €8.2 billion, and CET1 reached 15% despite €7.3 billion accrued for shareholder distributions.
UniCredit raised its 2026 net profit expectation to well above €11.5 billion before extraordinary charges and increased its interim cash dividend to €4.5 billion.

USA Rare Earth Inc

USAR Q3 2026

Reported: 2026-11-13

USA Rare Earth shares fell 9.6% after earnings, with investors likely focused on the revenue decline to $3 million for the quarter as shortages of dysprosium oxide and samarium-cobalt metal constrained supply. The transcript also does not provide quantified forward guidance, leaving the near-term impact of those shortages unclear despite progress across the business.

Key takeaways

Revenue was $3 million for the quarter and $14.5 million to date; management attributed lower quarter-on-quarter revenue to raw-material shortages.
The company ended the quarter with $1.2 billion in cash.
USA Rare Earth began commercial-scale MREC shipments from Cerro Verde in October and recorded sales in November; it also made its first magnet sale from Stillwater.
LCM had surpassed its full-year 2025 production by August, and management said it was on track to increase volumes by nearly 90% in 2020 despite industry-wide raw-material constraints.
Round Top’s resource-definition and upgrade drilling advanced; the company cited customer demand and several nonbinding MOUs covering a significant portion of anticipated oxide production.

Vestas Wind Systems A/S

VWDRY Q3 2026

Reported: 2026-11-13

Vestas shares fell 1.8% after earnings, a roughly flat reaction. The quarter showed higher revenue and margins, but the transcript also cited significant costs from the July blade incident and no offshore orders in Q3; management narrowed full-year guidance but did not provide the revised range in the available transcript.

Key takeaways

Q3 revenue was EUR 5.7 billion, up 6% year-on-year, while EBIT margin was 8.5%; EPS rose 21% to EUR 1.14.
Order intake was 3.4 GW, driven by onshore activity in EMEA and Asia Pacific. There were no offshore orders in the quarter.
Average selling price on new orders was EUR 1.22 million per MW, with management citing a favorable project mix that included 1 GW of Australian EPC contracts.
The July blade incident added significant operating costs, though Vestas said it contained the incident and maintained progress on offshore activity.
Service backlog reached a historical high of EUR 42 billion, up EUR 6 billion year-on-year; the combined Power Solutions and Service backlog was EUR 78 billion.

Wix.com Ltd.

WIX Q3 2026

Reported: 2026-11-13

Wix shares fell 2.0% after earnings, a roughly flat reaction. The call highlighted rapid expansion in newer AI products, while management also said it is accelerating Base44 marketing investment; the excerpt does not provide enough detail on consolidated results or guidance to identify a clear source of disappointment.

Key takeaways

Base44 is nearing $250 million in ARR, with demand in the second half running ahead of the company’s model and conversion from new free users to paid improving.
Base44 gross margin reached almost 60% in Q3. Wix is increasing marketing investment to capture demand, which could weigh on near-term economics.
Symphony, launched in August, has ARR in the millions of dollars, though management described it as still small.
Studio Two is live with partners and is designed to connect Wix’s workflow with external AI tools; management sees it as a potential route into an enterprise offering and a new upgrade path.
The provided transcript excerpt ends mid-sentence during management’s discussion of Base44 retention and does not include consolidated financial results or company guidance.

Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares

XNDU Q3 2026

Reported: 2026-11-13

Xanadu shares fell 9.4% after earnings, as the call emphasized a long-dated path to commercial utility—targeting up to 200 logical qubits in 2029—while management said meaningful revenue is not the near-term priority. The transcript provided also identifies loss reduction as the key engineering challenge but does not include enough of the financial discussion to assess quarterly performance.

Key takeaways

Management targets up to 200 logical qubits in 2029, up to 500 in 2030 and at least 1,000 from 2031 onward.
Reducing photon loss remains the company’s most important engineering challenge; management described it as primarily an engineering problem.
Xanadu said it is prioritizing its hardware road map over near-term revenue, though it sees potential for lower-distraction revenue from components or licensing.
The company announced hardware partnerships with GlobalFoundries, ASML and Bluefors, and cited new support from the Government of Canada and DARPA.
Xanadu reported progress with Mitsubishi Chemical on semiconductor-material modeling and said RBC and Booz Allen are using its software for workforce training.

Ypsomed Holding AG

YPSN.SW Q2 2027

Reported: 2026-11-13

Shares rose 10.8% after earnings, with investors responding to Ypsomed’s raised full-year guidance and a strong first half. New project wins and broad demand across therapeutic areas support the growth outlook, though management said autoinjectors are currently the clearest growth driver.

Key takeaways

Management raised full-year guidance, calling this the first guidance increase in Simon Michel’s 14 years as CEO; the transcript excerpt does not provide revised figures.
Ypsomed won 30 new projects in the half year—more than two-thirds of the prior full-year total—and added 10 customers, bringing its customer base to 130.
The company is active in close to 300 clinical and commercial programs: roughly 90 launched and 190 in development. The largest 10 customers account for about 50% of the portfolio.
More than 70% of revenue comes from autoinjectors and roughly one-third from pens; management identified autoinjectors as the current growth driver.
Management says pre-verification work has brought the time to prepare devices for clinical studies to below six months, with a target of three months.

Community

See what investors are trading, holding, and sharing

🌐

📈

📊

🏦

🪙

💱

#	Asset	Price	Community %	Type	Currency	Sector

2026 © AllInvestView

Twitter YouTube Reddit Feature Requests Changelog Support Pricing Help

Support email: [email protected]

Terms of Service | Privacy Policy

Free Trackers · Dividend Apps · Tax Reporting · UK · Australia · Germany · Guides · Ticker Logos

Stock Directory · Financial Glossary · Portfolio Templates · Top Dividend Stocks · Investing in US · Investing in UK · Import Guides · Stock Comparison · Earnings Recaps

Data disclaimer: AIV (AllInvestView) assumes no liability for the information presented. Users are encouraged to exercise caution and carefully consider the accuracy, completeness, and relevance of the information provided.

It's important to remember that our website should complement your independent market research rather than replace it. The past performance of assets should not be regarded as a guarantee of future results. AllInvestView is not a registered investment advisor or broker/dealer, and the information presented here is for educational and informational purposes only. We value your trust and are committed to providing you with valuable market insights while emphasizing the importance of responsible decision-making in your investment journey.